about
Polymorphous low-grade adenocarcinoma of the head and neckGeographic variation in human papillomavirus-related oropharyngeal cancer: Data from 4 multinational randomized trialsCD56 (NCAM) expression in ameloblastomas and other odontogenic lesions.Refining the diagnosis of oropharyngeal squamous cell carcinoma using human papillomavirus testing.Human Papillomavirus-associated oropharyngeal cancer: an observational study of diagnosis, prevalence and prognosis in a UK populationMitochondrial DNA mutations in head and neck cancer are infrequent and lack prognostic utility.Evaluation of human papilloma virus diagnostic testing in oropharyngeal squamous cell carcinoma: sensitivity, specificity, and prognostic discriminationThe formation of endoderm-derived taste sensory organs requires a Pax9-dependent expansion of embryonic taste bud progenitor cellsPATHOS: a phase II/III trial of risk-stratified, reduced intensity adjuvant treatment in patients undergoing transoral surgery for Human papillomavirus (HPV) positive oropharyngeal cancer.Oral precursor lesions and malignant transformation--who, where, what, and when?Transoral laser microsurgery for oropharyngeal squamous cell carcinoma: A paradigm shift in therapeutic approach.Intraoperative Sentinel Lymph Node Evaluation: Implications of Cytokeratin 19 Expression for the Adoption of OSNA in Oral Squamous Cell CarcinomaHPV specific testing: a requirement for oropharyngeal squamous cell carcinoma patientsPET-NECK: a multicentre randomised Phase III non-inferiority trial comparing a positron emission tomography-computerised tomography-guided watch-and-wait policy with planned neck dissection in the management of locally advanced (N2/N3) nodal metastaValidation of a novel diagnostic standard in HPV-positive oropharyngeal squamous cell carcinomaGenome-wide association analyses identify new susceptibility loci for oral cavity and pharyngeal cancer.HOPX functions as a tumour suppressor in head and neck cancer.Small cell neuroendocrine carcinoma of the oropharynx harbouring oncogenic HPV-infection.Salivary gland swellings.Salivary gland swellings.Twenty-first-century oral hairy leukoplakia--a non-HIV-associated entity.Upregulation of Eps8 in oral squamous cell carcinoma promotes cell migration and invasion through integrin-dependent Rac1 activation.HPV-Related Oropharynx Cancer in the United Kingdom: An Evolution in the Understanding of Disease Etiology.HPV Testing of Head and Neck Cancer in Clinical Practice.Trans-oral robotic assisted tongue base mucosectomy for investigation of cancer of unknown primary in the head and neck region. The UK experience.Pathology-based staging for HPV-positive squamous carcinoma of the oropharynx.Changes in Epidermal Growth Factor Receptor Gene Copy Number during Oral Carcinogenesis.Spindle assembly checkpoint and centrosome abnormalities in oral cancer.Metastatic dissemination of human malignant oral keratinocyte cell lines following orthotopic transplantation reflects response to TGF-beta 1.Combined effects of smoking and HPV16 in oropharyngeal cancer.Human papillomavirus and salivary gland neoplasia: a p16INK4 immunohistochemical and in situ hybridisation study.IGF-1R expression is associated with HPV-negative status and adverse survival in head and neck squamous cell cancer.Squamous cell carcinoma of the head and neck outside the oropharynx is rarely human papillomavirus related.Human papillomavirus testing in head and neck squamous cell carcinoma: best practice for diagnosis.Patients with HPV-related tonsil squamous cell carcinoma rarely harbour oncogenic HPV infection at other pharyngeal sites.Multicentric human papillomavirus-associated head and neck squamous cell carcinoma.An investigation into the practice of tongue piercing in the South West of England.Should we test for high-risk human papilloma virus in patients with oral dysplasia?PET-CT Surveillance versus Neck Dissection in Advanced Head and Neck Cancer.The influence of smoking, age and stage at diagnosis on the survival after larynx, hypopharynx and oral cavity cancers in Europe: The ARCAGE study.
P50
Q28271946-2A1BD446-C955-4AE1-9E5B-27117B30D5DEQ31036080-C9743E1C-385A-4EE3-83A0-0149A1D62FB8Q33704411-21A892E5-088B-47B8-B628-3775D8E5944FQ34103761-B5C2FD41-8C43-4D0C-89DE-990430A9CDF5Q34698871-25EF7B5B-4CE2-4156-9F38-C1B1BD8D2B0AQ34806878-DE69BF77-F6D2-4DE1-A8D4-D26E38CABD00Q35282198-CFA6EFD1-A3F7-46C9-BFDA-35525CEED5AEQ35317002-438D1ED7-1F68-4212-AEEB-3927BC1D6D93Q35756867-75E70826-F14D-48D6-B3E0-E1A612F3B3D5Q35781526-109C10D6-441F-42AB-9CB0-6E087348D155Q35978949-472D2B2F-79CC-49A0-8999-28F609CFBCFEQ36072045-6822563E-304B-4473-B582-CFDC686D2855Q36088094-801F9B87-247E-4694-A202-1CC8463C2570Q36346834-63306D60-6EAC-4BF2-9957-82073B56ACBAQ36747392-2D90618E-2660-4D65-9387-3FC24E9009C4Q37461632-E6EDEDF5-7D7C-4593-9FC9-59A9F07F22B1Q37488079-31AE017D-2A3C-4F84-B3B6-010020C64B3AQ37631286-1EA48DC2-3E30-424A-B310-0E8BE2C65353Q38055006-1C93FB43-967B-4586-98B8-8C3E2B09F187Q38082534-6B23B9CA-51AC-4A79-A46F-169597D761CFQ38324035-B5354E00-EA0C-497F-91E1-6DDFBCE0223FQ38354023-8A5C7C9D-E6A4-4A34-A94E-0DA23A37D272Q38377487-EF5C9C6E-B0C9-45BE-AD12-7ECA42C1CE8EQ38971546-772F5929-D73B-46B0-A2E0-785347018AA2Q39160876-95E7BADF-66D9-45FD-B736-9A96B7D1AEC0Q39172238-7EB18F43-EF44-4A55-8949-7BF1D640E6D2Q39752626-C6C6A09D-0432-4CC0-8A46-D89EA9F22C8CQ40062906-BB58701C-91BC-4CE1-8906-A19CA70C450EQ40534236-E82834E7-D9D4-4AB3-BFC3-F36FF80C7AA3Q40667356-B0F58B9D-FC28-4127-9F0A-BD6B59848FC3Q41100582-79D0607B-17DC-4661-B1EE-3C3E8649A9B1Q41303851-D8A08DE6-4116-46EF-AC14-628BDA55FCC3Q42205050-3A654F63-E4EB-4218-BCE4-6242867D5C11Q42206752-3312CB9A-652E-40B6-A273-41BF9680F373Q42242843-E479EA40-4173-490C-9534-250DDE45AA4EQ42246272-4C9E3C8C-342E-483A-8977-82FBF756EA67Q43779023-3A895489-04FB-49F7-9200-1EE6BC0B0318Q45336494-E6A7F7CC-C659-489D-AA25-FE4F2A248714Q47791594-C8A9FE01-DB2E-4D8D-B076-312451A40982Q48100092-7ECBD06A-269F-433B-941A-376FC0D03013
P50
description
researcher
@en
researcher
@en-gb
հետազոտող
@hy
name
Max Robinson
@ast
Max Robinson
@en
Max Robinson
@en-gb
Max Robinson
@es
Max Robinson
@nl
Max Robinson
@sl
type
label
Max Robinson
@ast
Max Robinson
@en
Max Robinson
@en-gb
Max Robinson
@es
Max Robinson
@nl
Max Robinson
@sl
altLabel
Robinson M
@en
prefLabel
Max Robinson
@ast
Max Robinson
@en
Max Robinson
@en-gb
Max Robinson
@es
Max Robinson
@nl
Max Robinson
@sl
P1053
R-5280-2018
P106
P1153
35729356700
P31
P496
0000-0003-4491-6865